Induction Task 2015
P1
The article summarises a new programme that will be given to newborn babies against meningitis B. Meningitis is an infection of the membrane which surrounds the brain and spinal cord. This can affect anyone but young children are more vulnerable to the infection. Some symptoms that have been shown from the infection are high fever with cold hands and feet, agitation, misperception, sickness and headaches.
These vaccinations will be given to babies at the ages of two, four and 12 months as a routine. The reason for the vaccination is so that there would be less risk of infants under the age of one getting the meningitis B infection. Campaigners have stated the vaccination could potentially prevent up to 4,000 cases by
For example Celiac Disease, Celiac disease is a disorder caused by a sensitivity to gluten.
I am going to talk about multi- disciplinary working what it means how they help service users by working together and also how it helps the overall services working with users. There are two case studies to help explain how professionals work together.
M3: Discuss the care strategies that can be used to support individuals with each physiological disorder.
In this report I will be describing different patterns of ill health and who and how they are monitored. I will also try to explain different factors that affect our health, not only now but I will try to discuss how different factors fight effect our health in the future, I will then evaluate the influence of the government have on factors that affect ill health.
It is the one the biggest challenges a child is taking on in their young adult life. They just graduated high school, and now they are moving into a college dormitory. They are taking a big step in their life; working for a bachelor’s degree in their highest interest. The doctor and the university is persistent in making sure the child has all their vaccinations. One major vaccination is the Meningococcal Meningitis shot. Meningitis takes a major toll on young adults, especially in the college setting. The last thing anyone wants to hear, is their child has died from Meningitis. Especially when there is a simple vaccination the child can obtained. Not to mention most universities, if not all, require the vaccine. Meningitis has
Meningococcal Meningitis is the infection and inflammation of the meninges. Newborns and infants are at greatest risk for contracting bacterial meningitis with Neisseria meningitides being the typical pathogen in the majority of children age 2 months through 12 years (London, Ladewig, Ball, Bindler, & Cowen, 2011). There is a mortality rate of 10% for children who develop meningitis from this particular bacterium (Muller, 2013).
meningitidis is the third leading causative pathogen and accounted for 45% of all bacterial meningitis cases in infants to children under age 6. Most of the cases were caused by capsular type b strains of H. meningitidis. In 1985, the first Hib vaccine was licensed in the United States, but it was not effective in infants and children younger than 18 months old. In December 1987, a more refined Hib vaccine, which is a conjugate vaccine. A conjugate vaccine is a vaccine containing bacterial capsular polysaccharide joined to a protein to enhance immunogenicity. Once this vaccine was improved and added as a regular vaccine for infants given at 2, 4, and 5 months of age, the incidence rate was reduced to 7% of all cases of bacterial meningitis. However, surveillance studies are still needed to monitor the non-type B strains, which is prevalent among children 6 years of age to
Variety of agents can cause bacterial meningitis. Since the introduction of new vaccine (Hib and PCV7), the pathogens responsible have changed. Presently, S. pneumaniae and Neisseria meningitidis are the leading cause of bacterial meningitis in children between 3 months and 19 years of age and Neisseria meningitidis is the leading cause in children between 10 and 19 years. The causative pathogen differs in children between 1 and 3 months. The leading cause of neonatal meningitis is group B streptococci about 39% and gram negative bacilli 32% (Nigrovic, Kupperman, and Malley, 2008)
Some forms of meningitis (such as those associated with meningococci, haemophilus influenzae type B, pneumococci or mumps virus infections) may be prevented by immunization.
According to the Meningitis ‘search for a cure’ documentary, doctors are researching for a universal vaccine, which can prevent the after-effects and remove this disease permanently from the body.58
Likewise, for many years, vaccinations have continued to keep the spread of diseases low. By doing this, they have lowered the amount of deaths and saved lives since their beginning. In fact,“It is estimated that just 9 of the routinely recommended vaccines prevent 42,000 deaths and 20 million cases of disease in every birth cohort” (Epling E1). Bacteria and viruses can take hold of their victims in a few different ways. For example, they can infect through the respiratory system, causing chest pain and coughing. One of the most fatal ways for children to be infected is through Meningitis. Meningitis is an infection, in the cerebrospinal fluid that surrounds the brain and spinal cord. During the infection, people can develop headaches,
children under five years of age are most at risk. A baby or young child with meningitis may:
The bacteria Neisseria meningitides, commonly known as meningococcus, is an important cause of bacterial meningitis worldwide. There are 13 serotypes, however globally, most meningococcal disease is caused by serogroups A, B, C, W135 and Y. (NCIRS:2014) Serotypes have varied geographical distribution, with serotypes B and C predominant in Europe, North America and Australia. The disease is serious and in some cases can be life threatening. The disease can cause meningitis (inflammation of membranes surrounding the brain and spinal cord, septicaemia, pneumonia, conjunctivitis and arthritis. (Australian Department of Health (ADOH:2014) This report is collated by the US Department of Health with the aim of identifying the categories of informational required to assess whether a meningoccaccal B vaccine should be included in the government funded National Immunization Program (Part 1). Part 2 will introduce the program evaluation of a case study of the MenB vaccine introduced in the US in a specific age group. Finally, this report will be submitted to the National Immunization Technical Advisory Group to make the final decision on whether the MenB vaccine will be included in the National Immunization Program. This decision will be included in the final section of the document.
Majority of the time meningitis is life threating if left untreated. So early treatment can help prevent serious problems including death. Vaccines can prevent some cases of bacterial
Meningococcal disease is a large concern in the medical field because it is unbiased towards the patients it infects. There has been limited success in trying to eliminate this disease. Antibiotics play a role in helping to treat patients with bacterial meningitis, and steroids have been tested to help reduce risk factors. Prevention has also become a key issue because meningitis can only be spread through direct contact with infected body fluid. The best prevention is to maintain clean hygiene. Vaccines are another way of preventing disease. However, there are multiple serogroups of meningitis that makes creating a universal vaccine extremely difficult. So far, there have only been two